Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

15

Number of overlapping holdings

11.0%

% of XBI's 136 holdings also in BBH

60.0%

% of BBH's 27 holdings also in XBI

Overlap by Weight
Sector Drift (XBI minus BBH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XBI
Weight
in BBH
Overlap
NATERA INC 3.5% 4.0% 3.5%
GILEAD SCIENCES INC 3.0% 10.9% 3.0%
VERTEX PHARMACEUTICALS INC 2.6% 10.8% 2.6%
ALNYLAM PHARMACEUTICALS INC 2.5% 3.3% 2.5%
NEUROCRINE BIOSCIENCES INC 2.8% 2.4% 2.4%

Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to BBH
UNITED THERAPEUTICS CORP 2.9%
ADVENTRX PHARMACEUTICALS INC 2.8%
ABBVIE INC 2.4%
MADRIGAL PHARMACEUTICALS, INC. 2.2%
VIKING THERAPEUTICS, INC. 1.9%
BLUEPRINT MEDICINES CORP. 1.7%
TG THERAPEUTICS INC 1.7%
CRISPR THERAPEUTICS AG 1.5%
HALOZYME THERAPEUTICS INC 1.4%
INCYTE CORP 1.3%
XBI Underweight Relative to BBH
AMGEN INC -13.1%
VERTEX PHARMACEUTICALS INC -8.2%
GILEAD SCIENCES INC -7.9%
ARGENX SE ADR -5.6%
REGENERON PHARMACEUTICALS -4.8%
IQVIA HOLDINGS INC -4.6%
ILLUMINA INC -4.4%
ICON PLC -3.5%
BIONTECH SE SPONSORED ADR -2.7%
BIO-TECHNE CORPORATION -2.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY